Product Center

White Papers

• A Comparison of CT/GC Results on the BD Viper™ System with XTR™ Technology Using Non-extracted vs. Extracted Modes
• Analytical Reproducibility of the BD Viper™ System with XTR™ Technology (extracted mode) for the Detection of Chlamydia trachomatis and Neisseria gonorrhoeae When Using the BD ProbeTec™ CT/GC Q^x Amplified DNA Assays
• BD Viper™ System with XTR™ Technology Time Study Comparing the Non-Extracted and Extracted Modes for the Detection of Chlamydia trachomatis and Neisseria gonorrhoeae
• Clinical Evaluation of the BD Viper™ System and the BD ProbeTec™ CTQx Amplified DNA Assay (CTQx) for the Direct Qualitative Screening of Chlamydia trachomatis (CT) in Female Endocervical, Female Vaginal, and Female Urine Specimens
• Comparison of Workflow and Analytical Sensitivity with Urine Specimens between the BD ProbeTec™ ET System and the BD Viper™ System in Extracted Mode.
• Detection of Chlamydia trachomatis and Neisseria gonorrhoeae in Urine using the BD ProbeTec™ CT Qx and GC Qx Amplified DNA Assays on the BD Viper™ System in Extracted Mode
• Detection of Chlamydia trachomatis and Neisseria gonorrhoeae on Endocervical and Vaginal Swabs with the BD ProbeTec™ CTQx and GCQx Amplified DNA Assays* on the BD Viper™ System in Extracted Mode*
• Endocervical Swab Performance from STD Clinics with the BD ProbeTec™ Chlamydia trachomatis (CT) Q^x Amplified DNA Assay and the BD ProbeTec™ Neisseria gonorrhoeae (GC) Q^x Amplified DNA Assay on the BD Viper™ System with XTR™ Technology (BD Viper System with XTR)
• Evaluation of the BD ProbeTec CTQ Amplified DNA Assay for Detection of the New Chlamydia trachomatis Variant in Sweden
• Evaluation of the BD Viper™ System in Extracted Mode* to Detect Chlamydia trachomatis and Neisseria gonorrhoeae in Male Swab and Urine Specimens
• Evaluation of the BD Viper™ System in Extracted Modeto Detect Chlamydia trachomatis and Neisseria gonorrhoeae in BD SurePath™ and Preservcyt® Cytology Specimens
• Performance of PreservCyt® Solution Specimens on the BD Viper™ System with XTR™ Technology Utilizing the BD ProbeTec™ Chlamydia trachomatis (CT) Q^x Amplified DNA Assay
• Performance of PreservCyt® Solution Specimens on the BD Viper™ System with XTR™ Technology with the BD ProbeTec™ Neisseria gonorrhoeae (GC) Q^x Amplified DNA Assay
• Performance of SurePath® Preservative Fluid Specimens with the BD ProbeTec CT/GC Q^x Amplified DNA Assays on the BD Viper™ System with XTR™ Technology
• Performance of the BD ProbeTec&rrade; CT/GC Q^x Amplified DNA Assays on the BD Viper™ System with XTR™ Technology Using Male Urine Samples
• Performance of the BD ProbeTec™ CT Qx and GC Qx Amplified DNA Assays with PreservCyt&red; Specimens on the BD Viper™ System in Extracted Mode
• Performance of the BD ProbeTec™CT Qx and GC Qx Amplified DNA Assays* with Urine and Vaginal Swab Specimens in the Presence of Potential Interfering Substances
• Performance of the BD Viper™ System in Extracted Mode* with the New BD ProbeTec™ Chlamydia trachomatis and Neisseria gonorrhoeae Qx Amplified DNA Assays*
• Reliability of the BD Viper™ System in Extracted Mode for the Detection of Chlamydia trachomatis and Neisseria gonorrhoeae
• Repeatability Evaluation of Specimens Tested with the BD ProbeTec™ CT/GC Q^x Amplified DNA Assays on the BD Viper™ System with XTR Technology
• Reproducibility of the BD Viper™ System with XTR™ Technology (Extracted Mode) with PreservCyt® Liquid Based Cytology Medium
• The Measurement of Reliability of the BD Viper™ System
• Vaginal Swab Performance on the BD Viper™ System with XTR™ Technology (Extracted Mode) for Detection of Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (GC) at Family Planning / OB/GYN Collection Sites - Perspectives in Clinical Care
• Work Flow Efficiencies and Operator Advantages Determined for the BD™ Viper ER and the BD™ ProbeTec